Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 27 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 6899882

    Endothelial cell growth factor methods of isolation and expression

    The Regents of the University of California · Granted May 31, 2005 · Expires May 26, 2025

    expired
  2. US 6867022

    Replication deficient adenovirus vectors and methods of making and using them

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 15, 2005 · Expires Mar 10, 2025

    expired
  3. US 6855314

    AAV5 vector for transducing brain cells and lung cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2005 · Expires Feb 10, 2025

    expired
  4. US 6852321

    Lectin-derived progenitor cell preservation factor and methods of use

    The Regents of the University of California · Granted Feb 8, 2005 · Expires Feb 3, 2025

    expired
  5. US 6846652

    Viral vectors having enhanced effectiveness with reduced virulence

    THE ARIZONA BOARD OF REGENTS · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  6. US 6846809

    PEI: DNA vector formulations for in vitro and in vivo gene delivery

    The Board of Regents of the University of Texas System · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  7. US 6838437

    Inactivation resistant factor VIII

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 4, 2005 · Expires Dec 30, 2024

    expired
  8. US 6833132

    Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 21, 2004 · Expires Dec 16, 2024

    expired
  9. US 6825323

    Compositions for treatment of hemorrhaging with activated factor VIIa in combination with fibrinogen and methods of using same

    The United States of America as represented by the Secretary of the Army · Granted Nov 30, 2004 · Expires Nov 25, 2024

    expired
  10. US 6821750

    ABCG8 vectors, host cells, and method of making

    The Board of Regents of the University of Texas System · Granted Nov 23, 2004 · Expires Nov 18, 2024

    expired
  11. US 6812336

    Transcription factor coactivator protein, p/CIP

    The Regents of the University of California · Granted Nov 2, 2004 · Expires Oct 28, 2024

    expired
  12. US 6806080

    Hybrid vectors for gene therapy

    The Regents of the University of California · Granted Oct 19, 2004 · Expires Oct 14, 2024

    expired
  13. US 6800454

    Nucleic acid molecule encoding chemokine-like factor 1 (CKLF1)

    Beijing Medical University United Biological Engineering Company · Granted Oct 5, 2004 · Expires Sep 30, 2024

    expired
  14. US 6800286

    Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof

    The Regents of the University of Colorado · Granted Oct 5, 2004 · Expires Sep 30, 2024

    expired
  15. US 6794188

    Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

    expired
  16. US 6780847

    Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

    expired
  17. US 6780837

    Prevention of retinal injury and degeneration by specific factors

    The Regents of the University of California · Granted Aug 24, 2004 · Expires Aug 19, 2024

    expired
  18. US 6767894

    Use of ciliary neurotrophic factor

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 27, 2004 · Expires Jul 22, 2024

    expired
  19. US 6749847

    Hybrid cytokine of IL-7 and &bgr;-chain of hepatocyte growth factor

    UNIVERSITY OF CONNECTICUT · Granted Jun 15, 2004 · Expires Jun 10, 2024

    expired
  20. US 6750043

    Viral vectors having reduced virulence

    THE ARIZONA BOARD OF REGENTS · Granted Jun 15, 2004 · Expires Jun 10, 2024

    expired
  21. US 6723841

    Corticotropin-releasing factor2 receptors

    Neurocrine Biosciences, Inc. · Granted Apr 20, 2004 · Expires Apr 15, 2024

    expired
  22. US 6709842

    DNA encoding a growth factor specific for epithelial cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 23, 2004 · Expires Mar 18, 2024

    expired
  23. US 6709858

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Mar 23, 2004 · Expires Mar 18, 2024

    expired
  24. US 6692750

    Alphavirus expression vector

    Bioption AB · Granted Feb 17, 2004 · Expires Feb 12, 2024

    expired